of pharmaceutical entrepreneurs eucope provides a platform for discussion for pharmaceutical entrepreneurs . on a regular basis owners and ceos of pharmaceutical companies and associations discuss solutions to improve the quality of life for patients and to strengthen the competitiveness of the european pharmaceutical industry . the legal framework for pharmaceutical markets is set largely by the eu institutions . an active role in the political debate on the eu level is therefore more important than ever before . the early perception of future markets and reliable regulatory circumstances are key aspects for entrepreneurial success . knowledge about this legal framework and the active discussion and participation on the eu level is therefore essential for pharmaceutical entrepreneurs in order to generate innovations . our services eucope understands itself as service provider for its members . the association provides its members with an early understanding about regulatory developments . current regulatory topics are ema transparency policy policy 0700 clinical trials regulation regulation eu no 536 2014 ema fees regulation regulation eu no 658 2014 commission proposal review ivd legislation commission proposal review medical devices legislation a tight monitoring and comprehensive information about future market conditions are valuable assets for entrepreneurial decisions . questions such as access to finance market access and reliable reimbursement conditions are of crucial importance for pharmaceutical entrepreneurs . please find out more about eucope under about us . conferences and working groups tuesday 15 november 2016 11am to 4pm eucope regulatory pharmacovigilance medical device working group meeting this working group is currently addressing the following topics ema prime scheme and adaptive pathways ... read more ... tuesday 22 november 2016 11am to 4pm eucope omp working group meeting this working group is currently addressing the following topics hta proceedings for omps review of ... read more ... tuesday 29 november 2016 11am to 4pm pricing and reimbursement market access working group meeting this working group is currently addressing the following topics member states use of unlicensed medicines ... read more ... eucope will be speaking at national hta assessment and value assessment in europe early dialogues health economics evaluation of orphans where are we heading in europe 29 30 september 2016 berlin more information can be found here . eucope news update revised eucope position paper on international reference pricing eucope updated its position paper on international reference pricing . you will find the document here updated position paper price differences in the eu open letter to european political institutions asks for transparency and collaboration as negotiations on a revised medical device framework near an end the european confederation of pharmaceutical entrepreneurs eucope has today published an open letter sent to members of the ... read more eucope comments on the draft notice on significant benefit for orphan medicinal products on 15 february eucope has submitted its comments on the draft commission notice on the application of articles ... read more you can find older posts in our news archives . contact eucope eucope aisbl rue marie de bourgogne 58 1000 brussels belgium 32 2 842 69 82 32 2 842 69 83 vat number be 0807 963 676 email office eucope.org contact us how to find us eucope en 2016 european confederation of pharmaceutical entrepreneurs aisbl rss feed for eucope news and press releases imprint disclaimer log in top of page